References
- Kociuba J, Łoziński T, Zgliczyńska M, et al. Occurrence of adverse events after magnetic resonance-guided high-intensity focused ultrasound (MR-HIFU) therapy in symptomatic uterine fibroids-a retrospective case-control study. Int J Hyperthermia. 2023;40(1):2219436. doi: 10.1080/02656736.2023.2219436.
- Silberzweig JE, Powell DK, Matsumoto AH, et al. Management of uterine fibroids: a focus on uterine-sparing interventional techniques. Radiology. 2016;280(3):675–692. doi: 10.1148/radiol.2016141693.
- Verpalen IM, Anneveldt KJ, Nijholt IM, et al. Magnetic resonance-high intensity focused ultrasound (MR-HIFU) therapy of symptomatic uterine fibroids with unrestrictive treatment protocols: a systematic review and meta-analysis. Eur J Radiol. 2019;120:108700. doi: 10.1016/j.ejrad.2019.108700.
- Mindjuk I, Trumm CG, Herzog P, et al. MRI predictors of clinical success in MR-guided focused ultrasound (MRgFUS) treatments of uterine fibroids: results from a single centre. Eur Radiol. 2015;25(5):1317–1328. doi: 10.1007/s00330-014-3538-6.
- Bitton RR, Fast A, Vu KN, et al. What predicts durable symptom relief of uterine fibroids treated with MRI-guided focused ultrasound? A multicenter trial in 8 academic centers. Eur Radiol. 2023;33(11):7360–7370. doi: 10.1007/s00330-023-09984-4.
- Tempany CM, Stewart EA, McDannold N, et al. MR imaging-guided focused ultrasound surgery of uterine leiomyomas: a feasibility study. Radiology. 2003;226(3):897–905. doi: 10.1148/radiol.2271020395.
- Luo W, Zhang PD, Yang X, et al. Role of contrast-enhanced ultrasonography in MR-guided focused ultrasound ablation on uterus fibroids: lesion selection and assessment of ablative effects. Eur Radiol. 2022;32(3):2110–2119. doi: 10.1007/s00330-021-08294-x.
- Idée JM, Port M, Robic C, et al. Role of thermodynamic and kinetic parameters in gadolinium chelate stability. J Magn Reson Imaging. 2009;30(6):1249–1258. doi: 10.1002/jmri.21967.
- Erdoğan MA, Apaydin M, Armagan G, et al. Evaluation of toxicity of gadolinium-based contrast agents on neuronal cells. Acta Radiol. 2021;62(2):206–214. doi: 10.1177/0284185120920801.
- Venkatesan AM, Partanen A, Pulanic TK, et al. Magnetic resonance imaging-guided volumetric ablation of symptomatic leiomyomata: correlation of imaging with histology. J Vasc Interv Radiol. 2012;23(6):786–794.e4. PMID: 22626269. doi: 10.1016/j.jvir.2012.02.015.
- Fruehauf JH, Back W, Eiermann A, et al. High-intensity focused ultrasound for the targeted destruction of uterine tissues: experiences from a pilot study using a mobile HIFU unit. Arch Gynecol Obstet. 2008;277(2):143–150. doi: 10.1007/s00404-007-0435-0.
- Viitala A, Gabriel M, Joronen K, et al. Histological findings in resected leiomyomas following MR-HIFU treatment, single-institution data from seven patients with unfavorable focal therapy. Int J Hyperthermia. 2023;40(1):2234666. doi: 10.1080/02656736.2023.2234666.
- Gencturk N, Cam I, Koksel Y, et al. Role of susceptibility-weighted imaging in detecting retinal hemorrhages in children with head trauma. Clin Neuroradiol. 2021;31(3):611–617. doi: 10.1007/s00062-020-00939-6.
- Hsu CC, Sethi SK, Haacke EM. The current state of susceptibility-weighted imaging and quantitative susceptibility mapping in head trauma. Neuroimaging Clin N Am. 2023;33(2):343–356. doi: 10.1016/j.nic.2023.01.009.
- Takeuchi M, Matsuzaki K, Bando Y, et al. Evaluation of red degeneration of uterine leiomyoma with susceptibility-weighted mr imaging. Magn Reson Med Sci. 2019;18(2):158–162. doi: 10.2463/mrms.mp.2018-0074.
- Cimsit B, Yoldemir T, Guclu M, et al. Susceptibility-weighted magnetic resonance imaging for the evaluation of deep infiltrating endometriosis: preliminary results. Acta Radiol. 2016;57(7):878–885. doi: 10.1177/0284185115602147.
- Yamahana X, Katsumori T, Miura H, et al. Susceptibility weighted MRI after uterine artery embolization for leiomyoma. Magn Reson Imaging. 2019;58(1):32–37. doi: 10.1016/j.mri.2019.01.013.
- Liao C, Xiao Z, Lv F, et al. Non-contrast enhanced MRI for assessment of uterine fibroids’ early response to ultrasound-guided high-intensity focused ultrasound thermal ablation. Eur J Radiol. 2020;122:108670. doi: 10.1016/j.ejrad.2019.108670.
- Pilatou MC, Stewart EA, Maier SE, et al. MRI-based thermal dosimetry and diffusion-weighted imaging of MRI-guided focused ultrasound thermal ablation of uterine fibroids. J Magn Reson Imaging. 2009;29(2):404–411. doi: 10.1002/jmri.21688.
- Liu J, Wei J, Keserci B, et al. T2*-weighted imaging in the assessment of the non-perfused volume of uterine fibroids following magnetic resonance-guided high-intensity focused ultrasound ablation. Int J Gynaecol Obstet. 2016;132(1):100–102. doi: 10.1016/j.ijgo.2015.07.005.
- Zhang Q, Chen Y, Lai M, et al. Magnetic resonance imaging-guided focused ultrasound surgery in a swine adenomyosis model. Acad Radiol. 2023;30 Suppl 2: S220–S226. (doi: 10.1016/j.acra.2022.11.034.
- Felker WR, Dregely I, Chung DJ, et al. Irreversible electroporation: defining the MRI appearance of the ablation zone with histopathologic correlation in a porcine liver model. AJR Am J Roentgenol. 2017;208(5):1141–1146. doi: 10.2214/AJR.16.17207.